These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9034285)

  • 1. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats.
    Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
    Am J Hematol; 1997 Feb; 54(2):118-23. PubMed ID: 9034285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation.
    Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
    Am J Physiol; 1996 Sep; 271(3 Pt 1):L470-5. PubMed ID: 8843797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
    Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
    Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
    Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
    Blood; 1996 Jan; 87(2):642-7. PubMed ID: 8555486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
    Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
    Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation.
    Uchiba M; Okajima K; Murakami K; Johno M; Mohri M; Okabe H; Takatsuki K
    Am J Physiol; 1997 Oct; 273(4):L889-94. PubMed ID: 9357866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
    Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
    Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
    Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
    Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.
    Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
    Am J Physiol; 1997 Feb; 272(2 Pt 1):L197-202. PubMed ID: 9124369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats.
    Murakami K; Okajima K; Uchiba M; Johno M; Okabe H; Takatsuki K
    Thromb Haemost; 1996 Jun; 75(6):965-70. PubMed ID: 8822594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
    Aoshima K; Asakura H; Yamazaki M; Saito M; Kumabashiri I; Morishita E; Ontachi Y; Mizutani T; Ichino T; Matsuda T
    Semin Thromb Hemost; 1998; 24(3):227-31. PubMed ID: 9701452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
    Uchiba M; Okajima K
    Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATIII-independence of anticoagulant effect of human urinary soluble thrombomodulin.
    Imada K; Takahashi Y; Hosaka Y; Adachi T; Niina H; Mochizuki H
    Blood Coagul Fibrinolysis; 1999 Dec; 10(8):503-11. PubMed ID: 10636462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats.
    Uchiba M; Okajima K; Murakami K
    Thromb Res; 1998 Mar; 89(5):233-41. PubMed ID: 9645917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.
    Taylor FB; Chang AC; Peer GT; Mather T; Blick K; Catlett R; Lockhart MS; Esmon CT
    Blood; 1991 Jul; 78(2):364-8. PubMed ID: 2070073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation.
    Mizutani A; Okajima K; Uchiba M; Noguchi T
    Blood; 2000 Jun; 95(12):3781-7. PubMed ID: 10845910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
    Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
    Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombomodulin].
    Ohmori Y; Takahashi Y
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
    Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
    Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.